{
  "id": 17162549,
  "title": "Natera president John Fesko sells $699,939 in common stock",
  "url": "https://urgent.news/2026/10/30/natera-president-john-fesko-sells-699-939-in-common-stock",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-30T02:05:48.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/natera-president-john-fesko-sells-699939-in-common-stock-93CH-4985715"
  },
  "original_language": "en",
  "account": "Natera's President John Fesko made two stock sales totaling $699,939 in late October 2026. On October 27, he sold 781 shares at prices between $406.0 and $426.3404, and the following day he sold 898 more shares. These transactions were executed to fulfill tax obligations related to the vesting of Restricted Stock Units (RSUs). The sales came as Natera's stock approached a 52-week high of $437.41, following a 126% year-over-year increase. The transactions were made in accordance with a pre-approved Rule 10b5-1(c) trading plan. As of now, Fesko directly owns 195,578 shares of Natera. Natera recently exceeded Wall Street expectations with second-quarter revenue of about $753 million, leading the company to raise its full-year revenue guidance. Analysts have indicated a positive outlook for Natera, with BTIG raising its price target to $430 and RBC Capital increasing its target to $460, both citing strong performance in minimal residual disease testing.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}